Parathyroid Hormone-Related Protein for the Treatment of Postmenopausal Osteoporosis: Defining the Maximal Tolerable Dose

Context: PTH is the only approved skeletal anabolic agent for the treatment of human osteoporosis. Unlike PTH, which is a mixed anabolic and catabolic agent, PTHrP displays features suggesting that it may be a pure anabolic agent when intermittently administered. The full dose range of PTHrP is unkn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Horwitz, Mara J., Tedesco, Mary Beth, Garcia-Ocaña, Adolfo, Sereika, Susan M., Prebehala, Linda, Bisello, Alessandro, Hollis, Bruce W., Gundberg, Caren M., Stewart, Andrew F.
Formato: Artigo
Idioma:Inglês
Publicado em: The Endocrine Society 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2841539/
https://ncbi.nlm.nih.gov/pubmed/20061412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2009-0233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados